Pneumothorax as a Complication of Combination Antiangiogenic Therapy in Children and Young Adults with Refractory/Recurrent Solid Tumors

PURPOSE: Antiangiogenic agents show significant antitumor activity against various tumor types. In a study evaluating the combination of sorafenib, bevacizumab, and low-dose cyclophosphamide in children with solid tumors, an unexpectedly high incidence of pneumothorax was observed. We evaluated pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Interiano, Rodrigo B., McCarville, M. Beth, Wu, Jianrong, Davidoff, Andrew M., Sandoval, John, Navid, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758326/
https://www.ncbi.nlm.nih.gov/pubmed/25783402
http://dx.doi.org/10.1016/j.jpedsurg.2015.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758326/
https://www.ncbi.nlm.nih.gov/pubmed/25783402
http://dx.doi.org/10.1016/j.jpedsurg.2015.01.005

Ejemplares similares